Cadence Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-504,065
| Closed | -$1.01M | – | 439 |
|
|
2019
Q2 | $1.01M | Sell |
504,065
-16,880
| -3% | -$33.8K | 0.1% | 278 |
|
|
2019
Q1 | $2.25M | Buy |
520,945
+9,109
| +2% | +$39.3K | 0.2% | 154 |
|
|
2018
Q4 | $1.63M | Buy |
511,836
+159,440
| +45% | +$507K | 0.16% | 190 |
|
|
2018
Q3 | $1.85M | Buy |
+352,396
| New | +$1.85M | 0.1% | 280 |
|
|
2016
Q3 | – | Sell |
-273,812
| Closed | -$783K | – | 632 |
|
|
2016
Q2 | $783K | Buy |
273,812
+24,926
| +10% | +$71.3K | 0.06% | 353 |
|
|
2016
Q1 | $752K | Buy |
248,886
+48,920
| +24% | +$148K | 0.05% | 378 |
|
|
2015
Q4 | $694K | Buy |
199,966
+48,876
| +32% | +$170K | 0.05% | 408 |
|
|
2015
Q3 | $571K | Sell |
151,090
-44,543
| -23% | -$168K | 0.04% | 425 |
|
|
2015
Q2 | $1.12M | Sell |
195,633
-9,451
| -5% | -$53.9K | 0.06% | 396 |
|
|
2015
Q1 | $1.19M | Buy |
205,084
+1,870
| +0.9% | +$10.9K | 0.07% | 349 |
|
|
2014
Q4 | $1.15M | Sell |
203,214
-23,691
| -10% | -$134K | 0.07% | 359 |
|
|
2014
Q3 | $928K | Sell |
226,905
-6,270
| -3% | -$25.6K | 0.05% | 426 |
|
|
2014
Q2 | $1.06M | Sell |
233,175
-25,746
| -10% | -$117K | 0.05% | 416 |
|
|
2014
Q1 | $1.23M | Buy |
258,921
+7,161
| +3% | +$33.9K | 0.05% | 406 |
|
|
2013
Q4 | $1.18M | Buy |
251,760
+179,725
| +249% | +$845K | 0.04% | 401 |
|
|
2013
Q3 | $287K | Buy |
+72,035
| New | +$287K | 0.01% | 577 |
|